Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global chlorpheniramine maleate market size was valued at USD 514.9 million in 2023, with Europe holding a significant market share. The market is driven by the rising prevalence of allergic conditions. It is expected to grow at a CAGR of 5.7% during the forecast period of 2024-2032, with the values likely to attain USD 848.1 million by 2032.
Chlorpheniramine maleate is a widely popular antihistamine used to relieve symptoms like watery eyes, cough, runny nose, and rash from allergies, among others. The medication is usually taken orally and blocks histamine, a chemical released during an allergic reaction, to manage the associated symptoms. Given its antihistamine properties, over-the-counter chlorpheniramine maleate products are generally used to treat coughs and colds. Various clinical studies have also indicated its effectiveness in managing asthma, plasma cell gingivitis, and chronic urticaria. Thus, the rising clinical application of this antihistamine in treating various disease indications are significantly contributing to the Europe chlorpheniramine maleate market growth.
Allergic conditions are prevalent in Europe, affecting a substantial segment of the population. Recent data revealed that one-third of the people living in the United Kingdom suffer from an allergy, with nearly 49% of Britons reported to suffer from seasonal hay fever. Moreover, it is estimated that half of Europe’s population will be affected by allergies by 2025, which is expected to fuel the demand for allergy medications. Additionally, air pollution triggers allergic rhinitis and other respiratory allergies. For instance, aeroallergens can worsen asthma, which affects around 11% of the population in the United Kingdom . With the rising pollution levels and growing patient base suffering from allergies, the Europe chlorpheniramine maleate market share is poised to witness a surge in the coming years.
One of the major market trends is an increased emphasis on repurposing chlorpheniramine maleate and related products for new therapeutic indications. In January 2023, a case series published in Cureus Journal highlighted the efficacy of a chlorpheniramine maleate throat spray for managing symptoms associated with COVID-19-induced acute viral pharyngitis, a common respiratory illness. The study reported that the chlorpheniramine maleate-based throat spray resulted in significant improvement in symptoms within 3 days of use, reducing the overall time that the patient has symptoms. Such ongoing research initiatives that evaluate the efficacy of the antihistamine treatment in different disease indications are likely to augment the Europe chlorpheniramine maleate market value.
The incidence and severity of allergies tend to rise with age due to the development of chronic conditions and a decline in organ function. In the European Union, 21.3% of the population was estimated to be aged 65 years or older according to Eurostat data published in January 2023. Further, it was stated that the older population in the region is projected to increase significantly in the coming decades. With the rising number of older adults more likely to be affected by allergies, the market share for chlorpheniramine maleate products is expected to grow in the forecast period.
The report offers a detailed analysis of the market based on the following segments:
Market Breakup | Categories |
Dosage Form | Tablets, Syrup, Eye Drops, Others |
Application | Allergy, Hay Fever (Allergic Rhinitis), Common Cold, Watery Eyes, Itchy Throat/Skin, Anaphylactic Shock, Urticaria |
Distribution Channel | Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others |
Country | United Kingdom, Germany, France, Italy, Others |
The key features of the market report include funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Dosage Form |
|
Breakup by Application |
|
Breakup by Distribution Channel |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Chlorpheniramine Maleate Market Size
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The Europe chlorpheniramine maleate market is expected to be driven by the rising demand for the global chlorpheniramine maleate market, which is anticipated to grow at a CAGR of 5.7% during the forecast period of 2024-2032 and is likely to reach a market value of USD 848.1 million by 2032.
The growing prevalence of allergic conditions and the rising geriatric population in the region are fuelling the demand for the market.
One of the significant trends in the market is the increased emphasis on repurposing chlorpheniramine maleate and related products for new therapeutic indications. In January 2023, a case series published in Cureus Journal highlighted the efficacy of a chlorpheniramine maleate throat spray for managing symptoms associated with COVID-19-induced acute viral pharyngitis.
Based on the dosage form, the market is segmented into tablets, syrup, and eye drops, among others.
Distribution channels of the market are hospital pharmacies, retail pharmacies, and online pharmacies, among others.
Major applications of the chlorpheniramine maleate include allergy, hay fever (allergic rhinitis), common cold, watery eyes, itchy throat/skin, anaphylactic shock, and urticaria.
The market segmentation by countries includes the United Kingdom, Germany, France, and Italy, among others.
The key players in the market are Viatris Inc., Bayer AG, Merck KGaA, Johnson & Johnson Medical Limited, GSK plc, AstraZeneca, Sanofi, Cardinal Health, Novartis AG, and Teva Pharmaceutical Industries Ltd.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share